Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282119 · ClinicalTrials.gov registry record · NA
Can EmeraldLED Reshape Your Body With Continued Use?
A NA study of Body Composition, sponsored by Efforia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07282119 is a NA study of Body Composition that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 111-participant average among 20 other Body Composition trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07282119, a NA study of Body Composition, is actively recruiting participants, sponsored by Efforia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.
Conditions Studied
Interventions
- DEVICE EmeraldLED
Study Locations (1)
New York
- Efforia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-08-29 |
| Est. Completion | 2026-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07282119
The ClinicalTrials.gov registry entry for NCT07282119 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 20 other Body Composition trials with a reported enrollment target (10% lower). The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Body Composition appearing as the primary indexed condition, and to 1 intervention - of which EmeraldLED is the first listed.
NCT07282119 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07282119 about?
NCT07282119 is a clinical study titled "Can EmeraldLED Reshape Your Body With Continued Use?". Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.
What is the current status of trial NCT07282119?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-08-29. Estimated completion is 2026-08-29.
What conditions does trial NCT07282119 study?
This clinical trial studies the following conditions: Body Composition.
What interventions are being tested in trial NCT07282119?
The interventions under investigation include: EmeraldLED (DEVICE).
Who is sponsoring clinical trial NCT07282119?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282119 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Composition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
How Does Continued Use of Green Light Therapy Impact Outcomes?
RECRUITING · NA
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty
RECRUITING · NA
-
Discover Better Body Composition With Green Light!
RECRUITING · NA
-
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.